Holen Sie sich die Stockscreener-App
34.51
0.76%
-0.265
Handel nachbörslich:
34.67
0.165
+0.48%
Atricure Inc Aktie (ATRC) Neueste Nachrichten
Citizens reiterates AtriCure stock rating on product growth outlook - Investing.com
AtriCure (ATRC) Proxy filing Summary - Quartr
(ATRC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Needham Initiates AtriCure(ATRC.US) With Buy Rating, Announces Target Price $45 - Moomoo
Needham Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $45 - Moomoo
AtriCure (ATRC) Investor Day 2025 Summary - Quartr
Is AtriCure's (ATRC) Russell 2000 Defensive Debut Quietly Reframing Its Risk‑Reward Profile? - simplywall.st
AtriCure (ATRC) Jumps Nearly 7% as Healthcare Sector Sees Renewed InterestTotal Put Call - dars.gov.et
AtriCure to announce second quarter 2026 financial results - scanx.trade
AtriCure to Announce Second Quarter 2026 Financial Results - BioSpace
Form 4 AtriCure Inc For: 2 July By Investing.com - Investing.com Canada
AtriCure (ATRC) CEO adds 636 shares through 2018 Employee Stock Purchase Plan - Stock Titan
AtriCure, Inc. (ATRC) CSO acquires 636 ESPP shares at discount - Stock Titan
AtriCure (ATRC) CLO acquires 636 shares in ESPP purchase - Stock Titan
AtriCure (ATRC) COO adds ESPP shares in routine acquisition - Stock Titan
AtriCure (ATRC) CTO adds shares through discounted Employee Stock Purchase Plan - Stock Titan
AtriCure | 4: Statement of changes in beneficial ownership of securities-Officer Privitera Salvatore - Moomoo
Press Release: AtriCure to Announce Second Quarter 2026 Financial Results - Moomoo
GRANDEUR PEAK GLOBAL MICROCAP FUND's AtriCure Inc(ATRC) Holding History - GuruFocus
Enterprise value to revenue forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Price to book forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Price to sales forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Canaccord reiterates AtriCure stock Buy rating after FDA clearance - Investing.com UK
Canaccord reiterates AtriCure stock Buy rating after FDA clearance By Investing.com - Investing.com Nigeria
CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $55 - Moomoo
AtriCure (ATRC) Q2 2025 earnings summary - Quartr
AtriCure (ATRC) Joins Multiple Russell 2000 Defensive Indexes Is Its Risk Profile Evolving? - simplywall.st
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic - MedTech Dive
AtriCure, Inc.(NasdaqGM: ATRC) added to Russell 2000 Defensive Index - marketscreener.com
AtriCure, Inc. Actuals & Estimates (NASDAQ:ATRC) - TradingView
AtriCure, Inc. Actuals & Estimates (DUS:A5I) - TradingView
ATRC Forecast — Price Target — Prediction for 2027 - TradingView
How (ATRC) Movements Inform Risk Allocation Models - Stock Traders Daily
AtriCure stock trades up with limited momentum as technical resistance remains - Traders Union
AtriCure Inc (ATRC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ATRC PE Ratio & Valuation, Is ATRC Overvalued - Intellectia AI
AtriCure stock jumps 6.19% as streamlined ablation integration takes spotlight, AtriCure reports - Traders Union
AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock? - Yahoo Finance
AtriCure Inc (ATRC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AtriCure Inc (ATRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AtriCure Inc (ATRC) Institutional Confidence - TradingKey
AtriCure Inc (ATRC) Valuation: PE, PB & Fair Value Analysis - TradingKey
AtriCure Inc (ATRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AtriCure Inc (ATRC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AtriCure Inc (ATRC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AtriCure Inc (ATRC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AtriCure (ATRC) Holds Steady at $27.98: Consolidation Near Key Resistance LevelsHead and Shoulders - DonanımHaber
AtriCure (ATRC) Declines 2.8% as Shares Approach Critical Support at $26.58Sweep Order Flow - DonanımHaber
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
Do options traders know something about AtriCure stock we don't? - MSN
AtriCure (ATRC) Q1 2026 Earnings Transcript - AOL.com
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
AtriCure (ATRC) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
AtriCure Inc. (ATRC) Rallies 1.4% as Bullish Momentum Builds Above Key SupportIV Spike - Bölüm Sonu Canavarı
A Look At AtriCure (ATRC) Valuation As BoxX NoAF Trial Acceleration Draws Investor Attention - Yahoo Finance
AtriCure Accelerates Key Heart Disease Trial, Reports Strong Q1 2026 EarningsEarnings Season Outlook - dars.gov.et
AtriCure faces market doubts despite revenue growth; share prices fall. Insider optimism hints at potential turnaround, but long-term earnings are the focus. - Moomoo
AtriCure (ATRC) Advances Key Heart Disease Trial 12 Months Ahead of Schedule - Insider Monkey
0.63%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):